OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) Antibody

Biorbyt

OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) Antibody

10

Positive Control: MOLT-4 cells. Human peripheral blood leukocytes (hPBL). Human tonsil tissue (IHC). ELISA (For coating, order antibody without BSA);Flow Cytometry (1-2ug/million cells); Immunofluorescence (1-2ug/ml);,Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes); Optimal dilution for a specific application should be determined. ELISA, FC, IF, IHC

Flow Cytometry, ImmunoFluorescence, ELISA, ImmunoHistoChemistry

Research Use Only

Monoclonal

OX40/3108

1.0 mg/ml

Unconjugated

TNFRSF4

TNF receptor superfamily member 4

ACT35; ACT35 antigen; ATC35 antigen; CD134; CD134 antigen; IMD16; lymphoid activation antigene ACT35; OX40; OX40 antigen; OX40 cell surface antigen; OX40 homologue; OX40L receptor; TAX transcriptionally-activated glycoprotein 1 receptor; tax-transcriptionally activated glycoprotein 1 receptor; tumor necrosis factor receptor superfamily member 4; TXGP1L

Mouse

IgG2c

Tumor necrosis factor receptor superfamily member 4

OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target) Antibody

Human, Primate

-20°C,2°C to 8°C

12352203